Eric Klavins

Title: Eric Klavins: Innovator in Protein-Protein Interaction Screening

Introduction

Eric Klavins is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of protein-protein interaction screening, holding a total of 3 patents. His work is crucial for advancing our understanding of cellular functions and therapeutic development.

Latest Patents

One of Eric Klavins' latest patents focuses on high throughput protein-protein interaction screening in yeast liquid culture. This invention relates to methods and compositions that enable the high throughput screening of protein-protein interactions. By expressing protein fusions that are non-native to yeast, the invention allows for the replacement of endogenous sexual agglutination proteins. This facilitates library-by-library interrogation of protein interactions. The methods and compositions can be utilized for characterizing protein interaction networks in high throughput, assessing both binding affinity and specificity. This is essential for understanding cellular functions, screening therapeutic candidates, and evaluating engineered protein networks.

Career Highlights

Eric Klavins is affiliated with the University of Washington, where he continues to innovate and contribute to the scientific community. His research has garnered attention for its potential applications in various fields, including biotechnology and medicine.

Collaborations

Eric has collaborated with notable colleagues such as David Baker and David Younger, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Eric Klavins is a key figure in the realm of protein-protein interaction screening, with a focus on innovative methods that advance scientific understanding. His contributions are vital for future developments in therapeutic applications and protein engineering.